Log In
BCIQ
Print this Print this
 

gedatolisib (PF-05212384) (formerly PKI-587)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionDual inhibitor of mammalian target of rapamycin (mTOR; FRAP; RAFT1) and phosphoinositide 3-kinase (PI3K)
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1) ; Phosphoinositide 3-kinase (PI3K)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today